Ligand Pharmaceuticals Incorporated Earnings

The next earnings date for Ligand Pharmaceuticals Incorporated is March 4, 2026.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Ligand Pharmaceuticals Incorporated Earnings

Report Date	Estimated Earnings Per Share
03/04/2026	$2.05

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Ligand Pharmaceuticals Incorporated Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
11/06/2025	---	$3.09	60.10%
08/07/2025	---	$1.60	11.89%
05/05/2025	Before Market	$1.33	70.51%
02/25/2025	Before Market	$1.27	6.71%
11/07/2024	Before Market	$1.84	36.30%
08/06/2024	After Market	$1.40	32.08%
05/07/2024	After Market	$1.20	53.85%
02/27/2024	Before Market	$1.38	109.09%
11/08/2023	After Market	$1.02	67.21%
08/08/2023	After Market	$1.42	121.88%
05/04/2023	After Market	$2.28	156.18%
02/22/2023	After Market	$1.36	14.29%
11/07/2022	After Market	$1.31	204.65%
08/08/2022	After Market	$1.03	139.53%
05/04/2022	After Market	$0.58	-12.12%
02/17/2022	After Market	$1.80	31.39%
11/09/2021	After Market	$1.58	51.92%
07/29/2021	After Market	$1.63	19.85%
05/03/2021	After Market	$1.41	24.78%
02/03/2021	Before Market	$1.62	63.64%
10/30/2020	Before Market	$1.04	6.12%
08/03/2020	Before Market	$1	31.58%
05/06/2020	After Market	$0.89	34.85%
02/06/2020	After Market	$0.71	10.94%
11/05/2019	After Market	$0.49	-19.67%
07/30/2019	Before Market	$0.68	23.64%
05/02/2019	After Market	$1.16	13.73%
02/07/2019	After Market	$1.70	39.34%
11/08/2018	Before Market	$1.32	28.16%
08/06/2018	After Market	$2.59	10.68%
05/08/2018	After Market	$1.55	20.16%
02/21/2018	After Market	$1.31	10.08%
11/09/2017	After Market	$0.69	13.11%
08/07/2017	After Market	$0.67	45.65%
05/09/2017	After Market	$0.57	-9.52%
02/23/2017	After Market	$1.25	5.04%
11/03/2016	After Market	$0.62	5.08%
08/04/2016	Before Market	$0.50	25.00%
05/04/2016	Before Market	$0.97	44.78%
02/10/2016	After Market	$0.66	1.54%
11/09/2015	After Market	$0.56	33.33%
08/04/2015	After Market	$0.49	22.50%
05/11/2015	Before Market	$0.33	22.22%
02/09/2015	Before Market	$0.60	0.00%
10/27/2014	Before Market	$0.36	16.13%
08/04/2014	---	$0.24	71.43%
05/07/2014	---	$0.35	40.00%
02/11/2014	---	$0.28	47.37%
10/30/2013	---	$0.12	71.43%
08/01/2013	---	$0.07	40.00%
05/08/2013	---	$0.16	77.78%
02/13/2013	---	$0.19	-9.52%
11/05/2012	---	$-0.01	75.00%
08/08/2012	---	$-0.20	-900.00%
05/02/2012	---	$-0.03	-50.00%
02/07/2012	---	$0.24	242.86%
11/08/2011	---	$-0.09	-1,000.00%
08/08/2011	---	$-0.05	-145.45%
05/10/2011	---	$0.48	860.00%
02/15/2011	---	$0.12	500.00%
11/09/2010	---	$-3.60	-11,900.00%
08/05/2010	---	$-0.01	50.67%
05/05/2010	---	$-0.12	33.33%
02/09/2010	---	$0.06	150.00%
11/05/2009	---	$0.06	125.00%
08/03/2009	---	$-0.30	26.83%
05/06/2009	---	$-0.30	-11.11%
02/12/2009	---	$-4.56	-1,069.23%
11/06/2008	---	$-0.60	-100.00%
07/31/2008	---	$-0.30	28.57%
05/01/2008	---	$-0.60	-122.22%
02/20/2008	---	$0.36	500.00%
11/08/2007	---	$0.06	150.00%
08/08/2007	---	$0.01	103.63%
05/10/2007	---	$16.32	-2.16%
03/15/2007	---	$8.52	-15.98%
11/14/2006	---	$-1.26	-90.91%
08/09/2006	---	$-0.96	-77.78%
05/15/2006	---	$-11.01	---
03/16/2006	---	$-0.24	55.56%
11/18/2005	---	$-0.48	-380.00%
08/09/2005	---	$-0.72	---
05/15/2005	---	$-1.50	---
02/15/2005	---	$1.02	-60.00%
11/09/2004	---	$-0.54	-800.00%
08/03/2004	---	$-1.14	-216.67%
05/05/2004	---	$-1.08	-208.57%
03/03/2004	---	$0.60	252.94%
10/31/2003	---	$-0.96	-71.43%
07/28/2003	---	$-1.02	-22.89%
04/24/2003	---	$-1.32	-91.30%
02/25/2003	---	$-0.54	-2,800.00%
11/12/2002	---	$-0.60	-900.00%
08/13/2002	---	$-1.02	-88.89%
05/03/2002	---	$-0.42	-600.00%
03/11/2002	---	$-0.54	22.86%
10/26/2001	---	$-0.78	7.14%
08/01/2001	---	$-1.08	10.00%
04/30/2001	---	$-1.20	-5.26%
12/31/2000	---	$-1.34	---
09/30/2000	---	$-1.58	---
06/30/2000	---	$-1.78	---
03/31/2000	---	$-1.67	---
03/10/2000	---	$-2.88	-113.33%
11/15/1999	---	$-2.34	-25.81%
08/16/1999	---	$-2.40	-207.69%
05/13/1999	---	$-1.92	-6.67%
03/30/1999	---	$-3.54	-190.16%
11/18/1998	---	$-2.40	-95.12%
08/14/1998	---	$-2.70	-20.00%
05/18/1998	---	$-2.10	2.78%
02/05/1998	---	$-0.54	51.35%
11/13/1997	---	$-2.10	-16.67%
08/14/1997	---	$-1.92	-3.23%
05/14/1997	---	$-1.92	-8.47%
03/31/1997	Before Market	$-2.28	-21.28%
11/08/1996	Before Market	$-1.80	-1.69%
08/14/1996	Before Market	$-2.16	-30.91%
05/08/1996	Before Market	$-1.50	5.66%
03/28/1996	Before Market	$-1.86	0.00%
11/14/1995	Before Market	$-1.92	-113.33%
08/15/1995	---	$-1.14	86.62%
05/15/1995	---	$-1.86	29.55%
02/16/1995	---	$-2.16	16.28%
10/25/1994	---	$-2.52	13.70%
08/15/1994	---	$-3.06	-18.60%

More About Ligand Pharmaceuticals Incorporated

Website

https://www.ligand.com

Country

USA

Full Time Employees

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI, a dual endothelin and angiotensin II receptor antagonist for immunoglobulin A nephropathy; Ohtuvayre for respiratory disease; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; LYTENAVA to treat Opthamology; MEKINIST for cardiology; MINNEBRO for metabolic disease; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, JZP341, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; CE-furosemide for cardiology; CE-Meloxicam for neurology; V117, CX2101A, and Sitavig for infectious disease; REV-0100, OPT-302, and Reproxalap for opthamology; Vilazodone and Topiramate Injection for CNS; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.

“Ligand Pharmaceuticals Incorporated Earnings” Can Refer to the Ligand Pharmaceuticals Incorporated Earnings Date

Some people say “Ligand Pharmaceuticals Incorporated earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Ligand Pharmaceuticals Incorporated position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Ligand Pharmaceuticals Incorporated Stock on the Earnings Date

If you own Ligand Pharmaceuticals Incorporated stock (LGND) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Ligand Pharmaceuticals Incorporated might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Ligand Pharmaceuticals Incorporated shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Ligand Pharmaceuticals Incorporated Earnings

You can contact us any time if you would like to ask questions about Ligand Pharmaceuticals Incorporated earnings or anything else related to the stock market.